Stuart Schreiber (Maria Nemchuk, Broad Institute)
January 12, 2024 11:01 AM EST
People
Startups

The Bell Labs of biotech: Stu­art Schreiber has bil­lion­aire sup­port for new bio­med­ical in­sti­tute 

Kyle LaHucik

Senior Reporter

Every week, there is chat­ter of new routes to fund­ing drug de­vel­op­ment that ul­ti­mate­ly bring med­i­cines to pa­tients more quick­ly. On Fri­day, a group of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

No­vo and Viking present new MASH da­ta, but an­a­lysts re­main con­fi­dent in Madri­gal's Rezd­if­fra

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times